Metabolomic Analysis Identifies Glycometabolism Pathways as Potential Targets of Qianggan Extract in Hyperglycemia Rats

Qianggan formula, a designed prescription according to the Traditional Chinese Medicine (TCM) theory, is widely used in treating chronic liver diseases, and indicated to prevent blood glucose increase in patients via unknown mechanisms. To unravel the effects and underlying mechanisms of Qianggan fo...

Full description

Bibliographic Details
Main Authors: Mingzhe Zhu, Meng Li, Wenjun Zhou, Guangbo Ge, Li Zhang, Guang Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00671/full
id doaj-5fac1704e1314201a272913cff609ae8
record_format Article
spelling doaj-5fac1704e1314201a272913cff609ae82020-11-25T03:02:48ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-05-011110.3389/fphar.2020.00671448332Metabolomic Analysis Identifies Glycometabolism Pathways as Potential Targets of Qianggan Extract in Hyperglycemia RatsMingzhe Zhu0Mingzhe Zhu1Meng Li2Wenjun Zhou3Guangbo Ge4Li Zhang5Guang Ji6Institute of Digestive Diseases, China-Canada Center of Research for Digestive Diseases (ccCRDD), Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Digestive Diseases, China-Canada Center of Research for Digestive Diseases (ccCRDD), Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Digestive Diseases, China-Canada Center of Research for Digestive Diseases (ccCRDD), Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Digestive Diseases, China-Canada Center of Research for Digestive Diseases (ccCRDD), Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Digestive Diseases, China-Canada Center of Research for Digestive Diseases (ccCRDD), Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaQianggan formula, a designed prescription according to the Traditional Chinese Medicine (TCM) theory, is widely used in treating chronic liver diseases, and indicated to prevent blood glucose increase in patients via unknown mechanisms. To unravel the effects and underlying mechanisms of Qianggan formula on hyperglycemia, we administrated Qianggan extract to high fat and high sucrose (HFHS) diet rats. Results showed that four-week Qianggan extract intervention significantly decreased serum fasting blood glucose, hemoglobin A1c, and liver glycogen levels. Gas chromatography-mass spectrometry (GC-MS) approach was employed to explore metabolomic profiles in liver and fecal samples. By multivariate and univariate statistical analysis (variable importance of projection value > 1 and p value < 0.05), 44 metabolites (18 in liver and 30 in feces) were identified as significantly different. Hierarchical cluster analysis revealed that most differential metabolites had opposite patterns between pair-wise groups. Qianggan extract restored the diet induced metabolite perturbations. Metabolite sets enrichment and pathway enrichment analysis revealed that the affected metabolites were mainly enriched in glycometabolism pathways such as glycolysis/gluconeogenesis, pentose phosphate pathway, fructose, and mannose metabolism. By compound-reaction-enzyme-gene network analysis, batches of genes (e.g. Hk1, Gck, Rpia, etc) or enzymes (e.g. hexokinase and glucokinase) related to metabolites in enriched pathways were obtained. Our findings demonstrated that Qianggan extract alleviated hyperglycemia, and the effects might be partially due to the regulation of glycometabolism related pathways.https://www.frontiersin.org/article/10.3389/fphar.2020.00671/fullQianggan extracthyperglycemiaglycometabolismmetabolomicsgas chromatography-mass spectrometry
collection DOAJ
language English
format Article
sources DOAJ
author Mingzhe Zhu
Mingzhe Zhu
Meng Li
Wenjun Zhou
Guangbo Ge
Li Zhang
Guang Ji
spellingShingle Mingzhe Zhu
Mingzhe Zhu
Meng Li
Wenjun Zhou
Guangbo Ge
Li Zhang
Guang Ji
Metabolomic Analysis Identifies Glycometabolism Pathways as Potential Targets of Qianggan Extract in Hyperglycemia Rats
Frontiers in Pharmacology
Qianggan extract
hyperglycemia
glycometabolism
metabolomics
gas chromatography-mass spectrometry
author_facet Mingzhe Zhu
Mingzhe Zhu
Meng Li
Wenjun Zhou
Guangbo Ge
Li Zhang
Guang Ji
author_sort Mingzhe Zhu
title Metabolomic Analysis Identifies Glycometabolism Pathways as Potential Targets of Qianggan Extract in Hyperglycemia Rats
title_short Metabolomic Analysis Identifies Glycometabolism Pathways as Potential Targets of Qianggan Extract in Hyperglycemia Rats
title_full Metabolomic Analysis Identifies Glycometabolism Pathways as Potential Targets of Qianggan Extract in Hyperglycemia Rats
title_fullStr Metabolomic Analysis Identifies Glycometabolism Pathways as Potential Targets of Qianggan Extract in Hyperglycemia Rats
title_full_unstemmed Metabolomic Analysis Identifies Glycometabolism Pathways as Potential Targets of Qianggan Extract in Hyperglycemia Rats
title_sort metabolomic analysis identifies glycometabolism pathways as potential targets of qianggan extract in hyperglycemia rats
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2020-05-01
description Qianggan formula, a designed prescription according to the Traditional Chinese Medicine (TCM) theory, is widely used in treating chronic liver diseases, and indicated to prevent blood glucose increase in patients via unknown mechanisms. To unravel the effects and underlying mechanisms of Qianggan formula on hyperglycemia, we administrated Qianggan extract to high fat and high sucrose (HFHS) diet rats. Results showed that four-week Qianggan extract intervention significantly decreased serum fasting blood glucose, hemoglobin A1c, and liver glycogen levels. Gas chromatography-mass spectrometry (GC-MS) approach was employed to explore metabolomic profiles in liver and fecal samples. By multivariate and univariate statistical analysis (variable importance of projection value > 1 and p value < 0.05), 44 metabolites (18 in liver and 30 in feces) were identified as significantly different. Hierarchical cluster analysis revealed that most differential metabolites had opposite patterns between pair-wise groups. Qianggan extract restored the diet induced metabolite perturbations. Metabolite sets enrichment and pathway enrichment analysis revealed that the affected metabolites were mainly enriched in glycometabolism pathways such as glycolysis/gluconeogenesis, pentose phosphate pathway, fructose, and mannose metabolism. By compound-reaction-enzyme-gene network analysis, batches of genes (e.g. Hk1, Gck, Rpia, etc) or enzymes (e.g. hexokinase and glucokinase) related to metabolites in enriched pathways were obtained. Our findings demonstrated that Qianggan extract alleviated hyperglycemia, and the effects might be partially due to the regulation of glycometabolism related pathways.
topic Qianggan extract
hyperglycemia
glycometabolism
metabolomics
gas chromatography-mass spectrometry
url https://www.frontiersin.org/article/10.3389/fphar.2020.00671/full
work_keys_str_mv AT mingzhezhu metabolomicanalysisidentifiesglycometabolismpathwaysaspotentialtargetsofqiangganextractinhyperglycemiarats
AT mingzhezhu metabolomicanalysisidentifiesglycometabolismpathwaysaspotentialtargetsofqiangganextractinhyperglycemiarats
AT mengli metabolomicanalysisidentifiesglycometabolismpathwaysaspotentialtargetsofqiangganextractinhyperglycemiarats
AT wenjunzhou metabolomicanalysisidentifiesglycometabolismpathwaysaspotentialtargetsofqiangganextractinhyperglycemiarats
AT guangboge metabolomicanalysisidentifiesglycometabolismpathwaysaspotentialtargetsofqiangganextractinhyperglycemiarats
AT lizhang metabolomicanalysisidentifiesglycometabolismpathwaysaspotentialtargetsofqiangganextractinhyperglycemiarats
AT guangji metabolomicanalysisidentifiesglycometabolismpathwaysaspotentialtargetsofqiangganextractinhyperglycemiarats
_version_ 1724688305180639232